Two Sigma Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216M | Buy |
7,815,700
+4,007,200
| +105% | +$111M | 0.44% | 49 |
|
|
2025
Q1 | $108M | Buy |
3,808,500
+3,704,800
| +3,573% | +$105M | 0.24% | 87 |
|
|
2024
Q4 | $4.31M | Sell |
103,700
-252,800
| -71% | -$10.5M | 0.01% | 775 |
|
|
2024
Q3 | $23.8M | Buy |
+356,500
| New | +$23.8M | 0.06% | 284 |
|
|
2024
Q2 | – | Sell |
-3,500
| Closed | -$373K | – | 2597 |
|
|
2024
Q1 | $373K | Sell |
3,500
-31,300
| -90% | -$3.34M | ﹤0.01% | 1991 |
|
|
2023
Q4 | $3.46M | Buy |
+34,800
| New | +$3.46M | 0.01% | 984 |
|
|
2023
Q3 | – | Sell |
-23,900
| Closed | -$2.9M | – | 2502 |
|
|
2023
Q2 | $2.9M | Buy |
+23,900
| New | +$2.9M | 0.01% | 1008 |
|
|
2022
Q1 | – | Sell |
-14,225
| Closed | -$3.61M | – | 2844 |
|
|
2021
Q4 | $3.61M | Sell |
14,225
-447,800
| -97% | -$114M | 0.01% | 916 |
|
|
2021
Q3 | $178M | Sell |
462,025
-141,900
| -23% | -$54.6M | 0.46% | 52 |
|
|
2021
Q2 | $142M | Buy |
603,925
+446,100
| +283% | +$105M | 0.37% | 65 |
|
|
2021
Q1 | $20.7M | Sell |
157,825
-443,200
| -74% | -$58M | 0.06% | 352 |
|
|
2020
Q4 | $62.8M | Buy |
601,025
+497,825
| +482% | +$52M | 0.17% | 130 |
|
|
2020
Q3 | $7.3M | Buy |
+103,200
| New | +$7.3M | 0.02% | 626 |
|
|
2020
Q2 | – | Sell |
-7,600
| Closed | -$228K | – | 2562 |
|
|
2020
Q1 | $228K | Buy |
+7,600
| New | +$228K | ﹤0.01% | 2123 |
|
|
2019
Q3 | – | Sell |
-12,600
| Closed | -$184K | – | 2337 |
|
|
2019
Q2 | $184K | Buy |
+12,600
| New | +$184K | ﹤0.01% | 2145 |
|